Molecules 2019, 24, 1231
7 of 10
δ
δ
211.9, 137.7, 128.8, 128.1, 127.6, 78.8, 52.4, 43.8, 42.6, 33.1, 28.4, 24.9; detectable peaks of anti-3aa
:
210.4, 138.3, 128.6, 128.2, 127.4, 76.4, 53.7, 42.9, 42.2, 29.8, 27.3; SFC: Daicel Chiralpak IC-3 ( = 210 nm,
λ
CO2/2-propanol, 93:7, 1.0 mL/min, 30 ◦C), tr (major) = 3.56 min, tr (minor) = 4.70 min.
(S)-2-((R)-1-(4-Methoxyphenyl)-2-nitroethyl)cyclohexanone (3ab) [44]. Yellow solid (94.6 mg, 68%);
1H-NMR (400 MHz, CDCl3) syn-3ab
7.08 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 4.91 (dd,
J = 12.4, 4.8 Hz, 1H), 4.58 (dd, J = 12.4, 10.0 Hz, 1H), 3.78 (s, 3H), 3.74–3.68 (m, 1H), 2.68–2.61 (m, 1H),
2.50–2.34 (m, 2H), 2.11–2.04 (m, 1H), 1.82–1.52 (m, 4H), 1.28–1.18 (m, 1H); detectable peaks of anti-3ab
7.20–7.16 (m, 0.09H), 4.87–4.71 (m, 0.13H), 3.96–3.88 (m, 0.06H); 13C-NMR (100.5 MHz, CDCl3)
syn-3ab 212.0, 158.8, 129.4, 129.0, 114.1, 79.0, 55.1, 52.5, 43.1, 42.6, 33.0, 28.4, 24.9; detectable peaks
of anti-3ab
:
δ
:
δ
:
δ
:
δ 210.6, 158.7, 129.3, 113.9, 76.9, 53.7, 42.4, 42.2, 30.0, 27.2; SFC: Daicel Chiralpak AD-3,
(λ = 220 nm, CO2/methanol, 95:5, 1.0 mL/min, 30 ◦C), tr (minor) = 5.90 min, tr (major) = 8.61 min.
(S)-2-((R)-1-(4-Bromophenyl)-2-nitroethyl)cyclohexanone (3ac) [44]. White solid (135.7 mg, 83%); 1H-NMR
(400 MHz, CDCl3) syn-3ac: δ 7.48–7.43 (m, 2H), 7.20–7.04 (m, 2H), 4.93 (dd, J = 12.8, 4.6 Hz, 1H),
4.60 (dd, J = 12.8, 10.1 Hz, 1H), 3.75 (td, J = 9.8, 4.4 Hz, 1H), 2.68–2.62 (m, 1H), 2.50–2.45 (m, 1H),
2.42–2.33 (m, 1H), 2.12–2.06 (m, 1H), 1.83–1.55 (m, 4H), 1.23 (qd, J = 12.4, 3.5 Hz, 1H); detectable peaks
of anti-3ac
2.75–2.70 (m, overlapped with syn-3ac, 0.11H), 1.94–1.87 (m, 0.13H), 1.42–1.31 (m, 0.11H); 13C-NMR
(100.5 MHz, CDCl3) syn-3ac 211.4, 136.8, 131.9, 129.8, 121.5, 78.4, 52.1, 43.3, 42.6, 33.0, 28.3, 24.9;
detectable peaks of anti-3ac
IC-3, (
: δ 7.44–7.43 (m, 0.26H), 7.16–7.14 (m, 0.21H), 4.89–4.78 (m, 0.21H), 3.94–3.89 (m, 0.12H),
:
δ
:
δ
210.2, 137.3, 131.7, 130.1, 76.4, 53.4, 42.2, 30.0, 27.2; SFC: Daicel Chiralpak
◦
λ
= 220 nm, CO2/2-propanol, 95:5, 1.0 mL/min, 30 C), tr (major) = 6.22 min, tr (minor) = 9.62 min.
(S)-2-((R)-1-Naphthyl-2-nitroethyl)cyclohexanone (3ad) [44]. Off-white solid (105.1 mg, 71%); 1H-NMR
(400 MHz, CDCl3) syn-3ad 7.82–7.77 (m, 3H), 7.67 (d, J = 26.5 Hz, 1H), 7.49–7.44 (m, 2H), 7.30–7.25
:
δ
(m, 1H), 5.03 (dd, J = 12.6, 4.3 Hz, 1H), 4.72 (dd, J = 12.8, 10.1 Hz, 1H), 3.95 (td, J = 10.1, 4.1 Hz,
1H), 2.76 (td, J = 11.1, 4.6 Hz, 1H), 2.49–2.32 (m, 2H), 2.05–2.00 (m, 1H), 1.71–1.49 (m, 4H), 1.28–1.19
(m, 1H); detectable peaks of anti-3ad
4.20–4.15 (m, 0.08H), 2.24 (m, 0.07H), 1.85–1.76 (m, 0.08H), 1.42–1.29 (m, overlapped with syn-3ad
0.04H); 13C-NMR (100.5 MHz, CDCl3) syn-3ad
211.8, 135.0, 133.2, 132.7, 128.7, 127.7, 127.5, 126.3,
126.0, 125.1, 78.7, 52.3, 44.0, 42.6, 33.2, 28.4, 24.9; detectable peaks of anti-3ad 210.4, 135.8, 133.1,
: δ 7.69 (s, 0.12H), 7.39–7.36 (m, 0.11H), 4.96–4.93 (m, 0.13H),
,
:
δ
:
δ
132.5, 128.4, 127.5, 126.9, 126.4, 126.2, 126.0, 76.4, 53.7, 42.9, 42.2, 29.8, 27.2; SFC: Daicel Chiralpak OD-3,
(λ = 210 nm, CO2/2-propanol, 82:18, 1.0 mL/min, 30 ◦C), tr (major) = 1.34 min, tr (minor) = 1.73 min.
(S)-3-((R)-2-Nitro-1-phenylethyl)tetrahydro-4H-thiopyran-4-one (3ba) [39]. White solid (100.8 mg, 76%);
1H-NMR (400 MHz, CDCl3) syn-3ba
:
δ
7.36–7.17 (m, 5H), 4.73 (dd, J = 12.8, 4.6 Hz, 1H), 4.61 (dd,
J = 12.8, 9.6 Hz, 1H), 3.96 (td, J = 10.3, 4.7 Hz, 1H), 3.06–2.93 (m, 3H), 2.87–2.77 (m, 2H), 2.62–2.41 (m, 2H);
detectable peaks of anti-3ba 4.90–4.81 (m, 0.02H), 4.18–4.13 (m, 0.03H), 2.94–2.92 (m, overlapped
with syn-3ba, 0.06H); 13C-NMR (100.5 MHz, CDCl3) syn-3ba
209.5, 136.4, 129.3, 128.3, 128.1, 78.6,
54.9, 44.5, 43.4, 35.1, 31.6; detectable peak of anti-3ba 129.0; SFC: Daicel Chiralpak IC-3, ( = 210 nm,
CO2/methanol, 96:4, 1.0 mL/min, 30 ◦C), tr (major) = 2.41 min, tr (minor) = 2.75 min.
:
δ
:
δ
:
δ
λ
(S)-2-((R)-2-Nitro-1-phenylethyl)cyclopentan-1-one (3ca) [44]. Off-white solid (13.7 mg, 12%); 1H-NMR
(400 MHz, CDCl3) syn-3ca 7.32 (s, 3H), 7.14 (s, 2H), 5.32 (dd, J = 12.8, 5.5 Hz, 1H), 5.00 (d, J = 7.8 Hz,
:
δ
1H), 4.70 (dd, J = 12.8, 10.1 Hz, 1H), 3.82 (dd, J = 11.9, 7.8 Hz, 1H), 3.71–3.65 (m, 1H), 2.36 (d, J = 43.9 Hz,
1H), 2.12 (d, J = 41.6 Hz, 1H), 1.89 (d, J = 49.4 Hz, 1H), 1.70 (d, J = 34.8 Hz, 1H), 1.47 (d, J = 41.6 Hz,
1H); detectable peaks of anti-3ca
0.34H), 2.29–2.25 (m, overlapped with syn-3ca, 0.16H), 1.41–1.20 (m, 0.17H); 13C-NMR (100.1 MHz,
CDCl3) syn-3ca 218.5, 137.7, 128.9, 128.4, 127.9, 78.2, 50.4, 44.1, 38.6, 28.3, 20.0; detectable peaks of
: δ 7.42–7.41 (m, 0.12H), 7.13–7.05 (m, 0.18H), 3.83 (td, J = 7.8, 4.1 Hz,
:
δ
anti-3ca
Chiralpak IA-3, (
:
δ
219.1, 137.3, 128.9 (overlapped with syn-3ca), 77.1, 51.4, 44.0, 39.2, 27.0, 20.5; SFC: Daicel
◦
λ
= 210 nm, CO2/2-propanol, 95:5, 1.0 mL/min, 30 C), tr (minor) = 1.70 min, tr (major)
= 2.56 min.